Battaglia S - Search Results

1

Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance.

Shaurova T, Dy GK, Battaglia S, Hutson A, Zhang L, Zhang Y, Lovly CM, Seshadri M, Goodrich DW, Johnson CS, Hershberger PA. Shaurova T, et al. Among authors: battaglia s. Cancers (Basel). 2020 Mar 13;12(3):675. doi: 10.3390/cancers12030675. Cancers (Basel). 2020. PMID: 32183160 Free PMC article.

2

Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.

Verone-Boyle AR, Shoemaker S, Attwood K, Morrison CD, Makowski AJ, Battaglia S, Hershberger PA. Verone-Boyle AR, et al. Among authors: battaglia s. Oncotarget. 2016 Jan 5;7(1):995-1013. doi: 10.18632/oncotarget.6493. Oncotarget. 2016. PMID: 26654942 Free PMC article.

3

Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.

McGray AJR, Huang RY, Battaglia S, Eppolito C, Miliotto A, Stephenson KB, Lugade AA, Webster G, Lichty BD, Seshadri M, Kozbor D, Odunsi K. McGray AJR, et al. Among authors: battaglia s. J Immunother Cancer. 2019 Jul 17;7(1):189. doi: 10.1186/s40425-019-0641-x. J Immunother Cancer. 2019. PMID: 31315674 Free PMC article.

4

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors.

Yamauchi T, Hoki T, Oba T, Jain V, Chen H, Attwood K, Battaglia S, George S, Chatta G, Puzanov I, Morrison C, Odunsi K, Segal BH, Dy GK, Ernstoff MS, Ito F. Yamauchi T, et al. Among authors: battaglia s. Nat Commun. 2021 Mar 3;12(1):1402. doi: 10.1038/s41467-021-21619-0. Nat Commun. 2021. PMID: 33658501 Free PMC article.

5

Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.

Odunsi K, Qian F, Lugade AA, Yu H, Geller MA, Fling SP, Kaiser JC, Lacroix AM, D'Amico L, Ramchurren N, Morishima C, Disis ML, Dennis L, Danaher P, Warren S, Nguyen VA, Ravi S, Tsuji T, Rosario S, Zha W, Hutson A, Liu S, Lele S, Zsiros E, McGray AJR, Chiello J, Koya R, Chodon T, Morrison CD, Putluri V, Putluri N, Mager DE, Gunawan R, Cheever MA, Battaglia S, Matsuzaki J. Odunsi K, et al. Among authors: battaglia s. Sci Transl Med. 2022 Mar 16;14(636):eabg8402. doi: 10.1126/scitranslmed.abg8402. Epub 2022 Mar 16. Sci Transl Med. 2022. PMID: 35294258 Free PMC article.

6

Reprogramming the tumor microenvironment leverages CD8⁺ T cell responses to a shared tumor/self antigen in ovarian cancer.

Mistarz A, Winkler M, Battaglia S, Liu S, Hutson A, Rokita H, Gambotto A, Odunsi KO, Singh PK, McGray AJR, Wang J, Kozbor D. Mistarz A, et al. Among authors: battaglia s. Mol Ther Oncolytics. 2023 Feb 9;28:230-248. doi: 10.1016/j.omto.2023.02.002. eCollection 2023 Mar 16. Mol Ther Oncolytics. 2023. PMID: 36875325 Free PMC article.

7

Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer.

Bruggemann L, Falls Z, Mangione W, Schwartz SA, Battaglia S, Aalinkeel R, Mahajan SD, Samudrala R. Bruggemann L, et al. Among authors: battaglia s. Int J Mol Sci. 2023 Jan 5;24(2):997. doi: 10.3390/ijms24020997. Int J Mol Sci. 2023. PMID: 36674513 Free PMC article.

8

Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer.

Tsuji T, Eng KH, Matsuzaki J, Battaglia S, Szender JB, Miliotto A, Gnjatic S, Bshara W, Morrison CD, Lele S, Emerson RO, Wang J, Liu S, Robins H, Lugade AA, Odunsi K. Tsuji T, et al. Among authors: battaglia s. Oncotarget. 2020 Jul 7;11(27):2669-2683. doi: 10.18632/oncotarget.27666. eCollection 2020 Jul 7. Oncotarget. 2020. PMID: 32676168 Free PMC article.

9

VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.

Singh PK, Long MD, Battaglia S, Hu Q, Liu S, Sucheston-Campbell LE, Campbell MJ. Singh PK, et al. Among authors: battaglia s. Epigenetics. 2015;10(1):40-9. doi: 10.4161/15592294.2014.989088. Epub 2015 Jan 29. Epigenetics. 2015. PMID: 25494645 Free PMC article.

10

LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.

Battaglia S, Karasik E, Gillard B, Williams J, Winchester T, Moser MT, Smiraglia DJ, Foster BA. Battaglia S, et al. Clin Epigenetics. 2017 Aug 11;9:82. doi: 10.1186/s13148-017-0382-y. eCollection 2017. Clin Epigenetics. 2017. PMID: 28811844 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters